MOTS-C Hilma Biocare 10 mg

MOTS-c by Hilma Biocare is a 16-amino-acid mitochondrial signalling peptide that plays a central role in metabolism, energy production, insulin sensitivity, endurance and healthy aging. Produced naturally inside the mitochondria, it can influence gene expression in the cell nucleus to help the body adapt to metabolic stress. Because its activity rises with exercise, MOTS-c is often called an "exercise-mimetic" — a peptide that supports fat metabolism, performance and mitochondrial efficiency. Each vial holds 10 mg of lyophilized peptide.
| Active substance | MOTS-c (mitochondrial peptide) |
| Manufacturer | Hilma Biocare |
| Strength | 10 mg per vial |
| Form | Lyophilized powder for reconstitution |
| Focus | Metabolism, endurance, longevity |
| Class | Mitochondrial-derived peptide |
Effects and benefits
MOTS-c activates AMPK, a master switch of cellular energy, which improves metabolic flexibility, supports fat loss and enhances the way muscles use glucose. Its links to endurance and insulin sensitivity make it popular in both performance and healthy-aging protocols.
- Metabolic optimization and flexibility
- Fat-loss support via AMPK activation
- Improved insulin sensitivity
- Endurance and mitochondrial efficiency
Usage and administration
MOTS-c is reconstituted with bacteriostatic water and used in short, defined subcutaneous protocols, often timed around training to build on its exercise-mimetic action. As a research peptide it belongs alongside the rest of the peptides range rather than in an anabolic cycle.
Stacking and combinations
For a broader metabolic and longevity protocol, MOTS-c is often paired with other cellular-energy peptides such as NAD+ or SS-31 for mitochondrial support.
Why choose Hilma Biocare
Each vial is produced to consistent pharmaceutical standards with reliable peptide content you can trust. Explore the full Hilma Biocare catalogue to build a complete longevity stack.
| Characteristics | |
| Shelf Life | 36 months from manufacture date |
| Drug Class | Mitochondrial Signaling Peptide |
| Concentration | 10 mg per vial |
| Half-Life | Short, with prolonged biological activity beyond plasma presence |
| Detection Time | Not typically tested in standard drug screenings |
| Active Substance | MOTS-c |
| Dosage | 5-10 mg per week |
| Drug Category | Peptide |
| Form | Lyophilized powder |
| Product Packaging | 10 mg vial |
| Liver Toxicity | None |
| Chemical Structure | Synthetic 16-amino acid mitochondrial peptide |
